Stoke Therapeutics Inc Q4 Loss Decreases, Beats Estimates

(RTTNews) - Stoke Therapeutics Inc (STOK) announced Loss for fourth quarter that decreased from last year and beat the Street estimates.

The company's bottom line totaled -$10.48 million, or -$0.18 per share. This compares with -$26.96 million, or -$0.60 per share, last year.

Analysts on average had expected the company to earn -$0.53 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 707.5% to $22.61 million from $2.80 million last year.

Stoke Therapeutics Inc earnings at a glance (GAAP) :

-Earnings: -$10.48 Mln. vs. -$26.96 Mln. last year. -EPS: -$0.18 vs. -$0.60 last year. -Revenue: $22.61 Mln vs. $2.80 Mln last year.